A PET imaging agent for evaluating PARP-1 expression in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A PET imaging agent for evaluating PARP-1 expression in ovarian cancer

Published:2018-04-16 Issue:5 Volume:128 Page:2116-2126
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Makvandi Mehran,Pantel Austin,Schwartz Lauren,Schubert Erin,Xu Kuiying,Hsieh Chia-Ju,Hou Catherine^ORCID,Kim Hyoung,Weng Chi-Chang,Winters Harrison,Doot Robert,Farwell Michael D.,Pryma Daniel A.,Greenberg Roger A.,Mankoff David A.,Simpkins Fiona,Mach Robert H.,Lin Lilie L.

Funder

U.S. Department of Defense

U.S. Department of Energy

NIH NCI

Basser Center for BRCA University of Pennsylvania

Abramson Cancer Center Radiation Oncology, Hospital of the University of Pennsylvania

Marsha Rivkin Foundation

Kaleiodoscope of Hope Foundation

Paul Calabresi K12 Career Development Award

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/97992/files/pdf

Reference48 articles.

1. The current treatment of recurrent ovarian cancer

2. PARP inhibitors: Synthetic lethality in the clinic

3. Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

4. Niraparib in Recurrent Ovarian Cancer

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

2. Molecular genetics of pheochromocytoma/paraganglioma;Current Opinion in Endocrine and Metabolic Research;2024-09

3. Pharmacodynamic Activity of [¹⁸F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With BRCA1/2-Mutated Breast Cancer Receiving Talazoparib;JCO Precision Oncology;2024-08

4. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

5. The emerging role of PET/CT scanning in the treatment planning of ovarian cancer: A mini-review;Imaging;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3